Oral Guazuma Ulmifolia and Tecoma Stans on Metabolic Profile in Type 2 Diabetes
Type 2 Diabetes Mellitus
Enrolment: 40 · Results not recorded
Loading the evidence…
Nutraceutical · Guazuma ulmifolia aqueous stem-bark extract; botanical.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Type 2 Diabetes Mellitus
Enrolment: 40 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Doxorubicin-induced cardiotoxicity, cumulative 24 mg/kg intraperitoneally divided into six alternate-day doses on days 7, 9, 11, 13, 15 and 17, euthanasia on day 18
Doxorubicin raised cardiac malondialdehyde by about 48 per cent versus control, and co-treatment with 200 mg/kg oral GUEsb prevented this rise, giving malondialdehyde 19 per cent below control. The extract showed no acute toxicity at 2000 or 5000 mg/kg apart from raised creatinine at the highest do…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.